Apparel and Footwear Specialist Retailers in Israel: Ken Research

Apparel and footwear specialist retailers have very low margins in the local market. Therefore, companies have been trying to increase their margins in any way possible. Many have closed outlets that are not profitable and are decreasing the sales area of their outlets. A number of retailers have started combining their different outlets in order to minimise their overall operational costs. For example, Honigman & Sons has started to combine its women's and children's outlets into larger outlets...

Euromonitor International's Apparel and Footwear Specialist Retailers in Israel report offers insight into key trends and developments driving the industry. The report examines all retail channels to provide sector insight. Channels include hypermarkets, supermarkets, discounters, convenience stores, mixed retailers, health and beauty retailers, clothing and footwear retailers, furniture and furnishing stores, DIY and hardware stores, durable goods retailers, leisure and personal goods retailers. There are profiles of leading retailers, with analysis of their performance and the challenges they face. There is also analysis of non-store retailing: vending; homeshopping; internet retailing; direct selling, as available. Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Key topics covered in this topic:

Apparel and Footwear Specialist Retailers in Israel

Israel Apparel and Footwear Specialist Retailers Market

Israel Apparel and Footwear Specialist Retailers Market Size

Israel Apparel and Footwear Specialist Retailers Market Revenue

Apparel and Footwear Specialist Retailers Leading Brands

Apparel and Footwear Specialist Retailers Market

Apparel and Footwear Specialist Retailers Market Analysis

Israel Apparel and Footwear Specialist Retailers Competition Market

Israel Apparel and Footwear Specialist Retailers Market Forecast

Israel Apparel and Footwear Specialist Retailers Market Share

To know more, click on the link below:

https://www.kenresearch.com/consumer-products-and-retail/textile-apparel-and-footwear/apparel-footwear-specialist-retailers-israel/144339-95.html

Related Reports

https://www.kenresearch.com/consumer-products-and-retail/textile-apparel-and-footwear/apparel-footwear-specialist-retailers-india/144338-95.html

https://www.kenresearch.com/consumer-products-and-retail/textile-apparel-and-footwear/apparel-footwear-specialist-retailers-argentina/144337-95.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

South Africa Packaging Industry Research Report : Ken Research

Euromonitor International's Packaging in South Africa report offers insight into key trends and developments in the industry. The report also examines trends and prospect for various pack types and closures: metal packaging, rigid plastic, glass, liquid cartons, paper-based containers; flexible packaging.

South Africa's economy continued to struggle in 2016 with the country seeing only weak growth, unemployment rates rising and disposable income struggling. Because of this situation consumers looked for the best value for money when making purchases which led to rising sales of bulk pack sizes, small pack sizes, multipacks, and discounted products. This situation continued to influence the actions of retailers and manufacturers which looked to offer new pack sizes and price promotions.

Here you will get a detailed picture of the Packaging market,Pinpoint growth sectors and identify factors driving change,Understand the competitive environment, the market's major players and leading brands and Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Key topics covered in the Report:-

South Africa Packaging Industry Market Research Report

South Africa Packaging Industry Market Size

South Africa Packaging Industry Report

South Africa Packaging Industry Market

South Africa Packaging Industry Analysis

South Africa Packaging Industry Market Forecast

South Africa Packaging Industry Market Major Players

South Africa Packaging Industry Market Forecast

South Africa Packaging Industry Market Analysis

South Africa Packaging Industry Leading Competitors

To know more, click on the link below:

https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/packaging-industry-south-africa/144400-100.html

Related Reports:-

https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/packaging-industry-china/144399-100.html

https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/packaging-industry-in-the-us/143573-100.html

https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/packaging-industry-in-argentina/143572-100.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Transplantation therapeutics Global market Research Report – Ken Research

Frontier Pharma: Transplantation Therapeutics-A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation

In 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these occurring in the EU and 32,000 in the US. Approximately 60% of these were kidney transplants, with liver, heart, lung, pancreas and small bowel transplantations accounting for the other most common procedures (Dominguez-Gil and Matesanz, 2017). When a graft is transplanted from a genetically non-identical individual, the recipient’s immune system recognizes the graft as foreign.

This leads to an anti-graft immune response that involves T cells invading the new tissue, multiplying, and recruiting more immune cells to the transplant site in order to remove this foreign body. Depending on the nature of the incompatibility and the immune response, and acute or chronic rejection process can occur. Conversely, if the graft consists of hematopoietic stem cells or immune cells, there is a risk that they will mount an immune response against the host, known as graft versus host disease (GVHD). There are several safe pharmacological treatment options for acute rejections, but long-term treatment options remain unsatisfactory.

The risk of infection limits the effectiveness of these therapies, and improvements to their efficacy are also needed. Specific transplantation tolerance, in which alloreactive T cells are inactivated while the broader immune response is left intact, removing the need for broad immunosuppressant therapies, can be considered to be the ultimate goal for clinical transplantation. Compared with the overall immunology pipeline, in which there are 1,915 products, the transplantation pipeline is small, with only 244 products. However, of the 145 products in the transplantation pipeline with a disclosed molecular target, there are 65 first-in-class products, acting on a total of 63 distinct first-in-class targets, highlighting the fact that this pipeline displays strong levels of innovation.

There is a need for therapies that can achieve graft-specific immunosuppression, without having a general effect on the wider immune system. Which therapies and technologies currently in development are most likely to achieve this? There are 63 distinct first-in-class molecular targets in development for transplantation. Which of these hold the strongest potential in the clinic, and which are closest to reaching the market? How effective are current therapies for these indications, and how have they been able to improve the general prognosis in recent decades? Which molecule types and molecular targets are most prominent across transplantation therapy? Which specific types of transplantation are being most heavily studied across the pharmaceutical pipeline?

Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options for transplantation rejection. Identify leading products and key unmet needs within the market. Recognize trends in pipeline innovation by analyzing therapies by stage of development, molecule type and molecular target. Assess the therapeutic potential of first-in-class targets. Using a proprietary molecular target matrix assessment, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.

Key topics covered in the Report:-

Transplantation therapeutics Global Market Research Report

Transplantation therapeutics Global Market Size

Transplantation therapeutics Global Report

Transplantation therapeutics Global Market

Transplantation therapeutics Global Analysis

Transplantation therapeutics Global Market Forecast

Transplantation therapeutics Global Market Major Players

Transplantation therapeutics Global Market Forecast

Transplantation therapeutics Global Market Analysis

Transplantation therapeutics Global Leading Competitors

To know more, click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/frontier-pharmatransplantation-therapeutics/142624-91.html

Related Reports:-

https://www.kenresearch.com/healthcare/pharmaceuticals/stem-cell-transplantation-global-clinical-trials-review-h2-2016/65249-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/transplantation-global-clinical/9033-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Asia Pacific Home Furnishings Market Outlook

Asia Pacific has surpassed Western Europe and North America to become the largest and fastest-growing region for home furnishings. There is potential for growth in emerging economies due to dynamic population growth, urbanisation, and rising income levels, however, home furnishings is highly fragmented and many companies have yet to expand beyond their home markets. Successful companies will need to consider changing socio-economic structures, with an eye on regional expansion.

Euromonitor International's Home Furnishings in Asia Pacific global briefing offers the big picture view of the size and shape of the Home and Garden market. The report delivers strategic insight into some of the key areas of the market, including emerging regions, countries and categories, as well as pressing industry issues and white spaces. It identifies opportunities, analyses leading companies and brands, and offers analysis of major factors influencing the market. Forecasts illustrate how the market is set to change and criteria for success Product coverage: Gardening, Home Furnishings, Home Improvement, Homewares. Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Key topics covered in the report:

Asia Pacific Home Furnishings Market Outlook

Asia Pacific Home Furnishings Market Size

Asia Pacific Home Furnishings Market Trends

Asia Pacific Home Furnishings Market Revenue

Asia Pacific Home Furnishings Market Share

Asia Pacific Home Furnishings Market Analysis

Asia Pacific Home Furnishings Market Competition Analysis

Asia Pacific Home Furnishings Industry Growth Analysis

Asia Pacific Home Furnishings Market Demand

Asia Pacific Home Furnishings Market Volume

To know more, click on the link below:

https://www.kenresearch.com/consumer-products-and-retail/home-and-office-furnishings/home-furnishings-asia-pacific/144336-95.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

Philippines Baby Food Market Research Report-Ken Research

Euromonitor International's Baby Food in Philippines Report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2021 illustrate how the market is set to change.

Breastfeeding is actively promoted by advocacy groups such as the Breastfeeding Pinays which celebrated for the fourth year in August 2016 the event called "The Big Latch On" wherein mothers simultaneously breastfed their babies together with others in different parts of the world in celebration of National Breastfeeding Awareness Month. Breast milk is often promoted for its economic and health benefits. In 2016, the Department of Health undertook a house-to-house campaign in urban areas to prom.

Product coverage: Dried Baby Food, Milk Formula, Other Baby Food, Prepared Baby Food.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Baby Food market.

* Pinpoint growth sectors and identify factors driving change.

* Understand the competitive environment, the market's major players and leading brands.

* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Key topics covered in this report:

Philippines Baby Food Market Research Report

Philippines Baby Food Market Forecast

Philippines Baby Food Market Revenue

Philippines Baby Food Market Size

Philippines Baby Food Market Future Outlook

Philippines Baby Food Market Analysis

Philippines Baby Food Market Opportunities

Philippines Baby Food Market Competition

Philippines Baby Food Market Trends

Philippines Baby Food Market Shares

Philippines Baby Food Market Growth Analysis

Philippines Baby Food Market Value

Baby Food Market In Philippines

To know more, click on the link below:

https://www.kenresearch.com/food-beverage-and-tobacco/general-food/baby-food-in-the-philippines/143548-11.html

Related Reports:

https://www.kenresearch.com/consumer-products-and-retail/baby-care/hungary-future-foodservice/131152-95.html

https://www.kenresearch.com/consumer-products-and-retail/baby-care/the-baby-food-market-finland/112127-95.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Global Cardiovascular Disease Drugs Market to 2023: Ken Research

Global Cardiovascular Disease Drugs Market to 2023-Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

The Cardiovascular Disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque buildup within blood vessels. As atheroma develops it causes the affected blood vessels to narrow, restricting blood flow to the body, brain or heart, depending on its locale. It is also possible for the fibrous cap of this plaque to break off, triggering the coagulation cascade and causing a thrombus to form locally, which can completely occlude blood flow.

The treatments of CVD typically focus on prevention by controlling risk factors. As such, the treatments usually fall within three categories: Anti-hypertensives, which aim to maintain blood pressure within a normal range; anti-dyslipidemic drugs, which aim to modify lipid levels to a normal range; and anti-thrombotic drugs, which aim to prevent thrombi formation by inhibiting the coagulation cascade or platelet aggregation.

There has been vast scientific innovation in the CVD therapeutics market in recent decades, particularly within the anti-dyslipidemia market. This was seen first with the introduction of statins such as Lipitor (atorvastatin), and more recently with the introduction of protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. However, other areas such as the heart failure market remain poorly treated. Dyslipidemia and hypertension have continuing high levels of development within the current pipeline and, despite high levels of generic development, there is also a large degree of innovation, with targets such as apolipoproteins and elements of the reverse lipid transport pathway. In addition, the current pipeline includes nearly 200 products for the treatment of heart failure, suggesting an increase in interest in treating the disease.

With over 1,400 products in active development, the pipeline for CVD is extensive. Does current pipeline innovation hold the potential to change the CVD market in the near future? The clinical trials process for CVD drugs is complex. What is the risk of a CVD drug failing to reach the market? What is the risk of a drug failing at a specific Phase? The CVD market landscape is forecast to undergo a period of substantial change following key approvals, patent expiries and acquisitions. Which of the leading companies will have the highest market share by 2023? What strategies have these companies adopted to achieve market growth? There has been a moderately high level of deal activity in recent years. How do deal frequency and value compare between target families and molecule types?

Key topics covered in the report:

Global Cardiovascular Disease Drugs Market

Global Cardiovascular Disease Drugs Market Outlook

Global Cardiovascular Disease Drugs Market Value

Global Cardiovascular Disease Drugs Market Competition Analysis

Global Cardiovascular Disease Drugs Industry Growth Analysis

Global Cardiovascular Disease Drugs Market Size

Global Cardiovascular Disease Treatment

Heart Disease Treatment in Global

Global Cardiovascular Disease Drugs Market Forecast

Global Cardiovascular Disease Drugs Market Revenue

Global Cardiovascular Disease Drugs Market Share

Global Cardiovascular Disease Drugs Market SWOT Analysis

Global Cardiovascular Disease Drugs Market Demand

Global Heart Disease Medical Treatment

To know more, click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/global-cardiovascular-disease-drugs-market-to-2023/142623-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249